Watchlist Price Alert

Kura Oncology Inc. (KURA)

NASDAQ: KURA · Real-Time Price · USD

5.86

0.01 (0.17%)

At close: Jun 23, 2025, 3:59 PM

5.81

-0.77%

After-hours: Jun 23, 2025, 06:25 PM EDT

0.17% (1D)

Bid	5.75
Market Cap	506.89M
Revenue (ttm)	67.99M
Net Income (ttm)	-181.89M
EPS (ttm)	-2.09
PE Ratio (ttm)	-2.8
Forward PE	-3.21
Analyst	Buy

Ask	7.25
Volume	816,428
Avg. Volume (20D)	1,298,069
Open	5.83
Previous Close	5.85
Day's Range	5.72 - 5.93
52-Week Range	5.41 - 23.48
Beta	0.40

About KURA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol KURA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for KURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Kura Oncology Inc. is scheduled to release its earnings on Aug 7, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 weeks ago

+10.72%

Kura Oncology shares are trading higher after the ... Unlock content with Pro Subscription

4 months ago

-2.54%

Kura Oncology shares are trading lower. The company announced topline results from KOMET-001.

News

1 week ago · zacks.com

Is the Options Market Predicting a Spike in Kura Oncology Stock?

Investors need to pay close attention to KURA stock based on the movements in the options market lately.

2 weeks ago · zacks.com

KURA Stock Rises More Than 15% This Past Week: Here's Why

Kura Oncology shares rise this week after the FDA accepts its NDA for ziftomenib, a potential first-in-class treatment for NPM1-mutant AML.

1 month ago · seekingalpha.com

Kura Oncology, Inc. (KURA) Q1 2025 Earnings Call Transcript

Kura Oncology, Inc. (NASDAQ:KURA ) Q1 2025 Earnings Conference Call May 1, 2025 4:30 PM ET Company Participants Troy Wilson – President and Chief Executive Officer Mollie Leoni – Chief Medical Officer...

1 month ago · zacks.com

Kura Oncology (KURA) Reports Q1 Loss, Lags Revenue Estimates

Kura Oncology (KURA) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.59 per share a year ago.